FeiginVLBraininMNorrvingB, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke2022; 17: 18–29.
2.
KimJThayabaranathanTDonnanGA, et al. Global stroke statistics 2019. Int J Stroke2020; 15: 819–838.
3.
JonesSPBaqaiKCleggA, et al. Stroke in India: a systematic review of the incidence, prevalence, and case fatality. Int J Stroke2021; 17: 132–140.
4.
FerroJMDentaliFCoutinhoJM, et al. Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis. Int J Stroke2018; 13: 766–770.
5.
FerroJMCoutinhoJMDentaliF, et al. RE-SPECT CVT Study Group. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol2019; 76: 1457–1465.
6.
FerroJMBendszusMJansenO, et al.; RE-SPECT CVT Study Group. Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis. Int J Stroke2021; 17: 189–197.
7.
MohamedAFatimaNShuaibA, et al. Comparison of mothership versus drip-and-ship models in treating patients with acute ischemic stroke: a systematic review and meta-analysis. Int J Stroke2021; 17: 141–154.
8.
PodlasekADhillonPSButtW, et al. Direct mechanical thrombectomy without intravenous thrombolysis versus bridging therapy for acute ischemic stroke: a meta-analysis of randomized controlled trials. Int J Stroke2021; 16: 621–631.
